A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer.

Determination of CA 125 levels may aid in monitoring the response to treatment in patients with epithelial ovarian cancer, and rising or falling levels ofCA 125 correlated with progression or regression of disease in 42 of 45 instances.